Literature DB >> 2105636

Pure red cell aplasia following pernicious anemia.

K Dan1, T Ito, T Nomura.   

Abstract

A rare case of pure red cell aplasia (PRCA) in association with pernicious anemia is reported. A 40-year-old man presented with typical clinical and laboratory features of pernicious anemia and received intramuscular injections of vitamin B12, with satisfactory response. Anemia recurred 6 months later despite continued therapy, and the patient was noted to have PRCA, which was treated successfully with two courses of high-dose bolus methylprednisolone therapy. His peripheral mononuclear cells before the therapy suppressed colony formation of early erythroid precursors (BFU-E) from normal bone marrow; such a suppressive effect was not found after recovery from anemia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2105636     DOI: 10.1002/ajh.2830330215

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  2 in total

1.  Pure red cell aplasia caused by pegylated interferon-α-2a plus ribavirin in the treatment of chronic hepatitis C.

Authors:  Cheng-Shyong Chang; Sheng-Lei Yan; Hsuan-Yu Lin; Fu-Lien Yu; Chien-Yu Tsai
Journal:  World J Gastroenterol       Date:  2011-04-28       Impact factor: 5.742

2.  Associations Between Autoimmune Conditions and Gastric Cancer Risk Among Elderly Adults in the United States.

Authors:  Minkyo Song; M Constanza Camargo; Andriy Derkach; Charles S Rabkin; Eric A Engels
Journal:  Am J Gastroenterol       Date:  2022-03-01       Impact factor: 12.045

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.